LGBT / News and notes / Women and Alzheimer's
by Alzheimer's Association · Published June 26, 2023 · Last modified June 27, 2023
By Kerry Larkey, MSN, RN Sonja Lilienthal didn’t expect to receive an Alzheimer’s diagnosis, least of all at age 56. By that time, she was already in the practice of meticulously writing out each...
In late spring of 2022 investigators from the AHEAD Study were awarded grant funds for a new and unprecedented approach to engaging the Hispanic community in dementia research. The University of California, San Francisco...
by Jennifer Tinkelenberg · Published June 5, 2023 · Last modified June 16, 2023
While it’s important for everyone to plan for the future, legal plans are especially vital for a person diagnosed with dementia. The sooner these plans are put in place, the more likely it is...
By Sloane Ruuska, BSN, RN Have you ever seen a fleet of Corvettes cruising together in the East Bay? If so, you may have witnessed Larry’s fundraiser for The Longest Day®. This April, Larry...
By Chaka Morrison Keiko Kagawa is the music director of COSMO, a primarily Japanese singing group. In 2022, she was introduced to the Alzheimer’s Association® through a member of her choir. Since then, Keiko...
Jeanne Reuter and her daughter Sheila Reuter were surprised when their husband/father, Dick, started showing signs of cognitive decline. However, because of his diagnosis, this mother daughter duo found themselves raising more than $40...
by Alzheimer's Association · Published May 5, 2023 · Last modified May 16, 2023
By Kerry Larkey, MSN, RN Author, poet, daughter, caregiver and advocate; Frances Kakugawa shares her experiences to help others in Sacramento learn about Alzheimer’s disease. In 1999, her mother was diagnosed with Alzheimer’s and...
Advocacy / Early stage Alzheimer's voices / News and notes
by Jennifer Tinkelenberg · Published May 1, 2023 · Last modified May 11, 2023
Since 2021, the U.S. Food and Drug Administration (FDA) has approved two new treatments for Alzheimer’s and dementia, Aducanumab (Aduhelm™) and Lecanemab (Leqembi™), that slows progression. While these treatments work differently, they both target...
